Siemens Healthineers AG

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Siemens Healthineers AG is a holding company that provides healthcare equipment, solutions, and services globally. It operates through the following business segments: Imaging, Diagnotics, Varian and Advanced Therapies. The Imaging segment provides imaging products, services, and solutions as well as digital offerings. The Diagnostics segment provides a broad array of testing applications, in the areas of laboratory, point of care and molecular diagnostics. The Varian segment provides innovative, multi-modality cancer care technologies based on integrated, advanced imaging, along with solutions and services to oncology departments in hospitals and clinics globally. The Advanced Therapies segment consist of integrated products, services and solutions across multiple clinical fields used in the treatment of diseases. Siemens Healthineers was founded on December 1, 2017 and is headquartered in Forchheim, Germany.

Fiscal first quarter results were boosted by strong contributions from rapid antigen testing, but mixed core results were still better than peer results. The Imaging business looks poised to go from strength to strength with very strong new product ramps and supply woes at rivals.

The Siemens Healthineers Is Looking Better And Better

Siemens AG

Siemens Healthineers AG's (SEMHF) CEO Bernd Montag on Q1 2022 Results - Earnings Call Transcript

TARRYTOWN, N.Y.--(BUSINESS WIRE)--Siemens Healthineers announced today the CLINITEST® Rapid COVID-19 Antigen Self-Test1,2 is now available in the U.S. to self-test for the SARS-CoV-2 virus. The CLINITEST Rapid COVID-19 Antigen Self-Test uses a simple nasal swab to provide accurate COVID-19 test results (including for both the Omicron and Delta variants) in 15 minutes and comes in a five-test-per-box configuration—convenient for families, group, and/or serial testing needs. The test is approved

Millions of Siemens Healthineers CLINITEST Rapid COVID-19 Antigen Self-Test Now Available in the U.S.

TARRYTOWN, N.Y.--(BUSINESS WIRE)--Siemens Healthineers announces that the U.S. Food and Drug Administration (FDA) today granted Emergency Use Authorization (EUA) for the CLINITEST Rapid COVID-19 Antigen Self-Test,1, 2, 3 providing nationwide access to a new at-home or over-the-counter self-test as COVID-19 testing needs continue to grow for individuals, families, and businesses. The easy-to-use nasal swab test is intended to aid in the rapid detection of SARS-CoV-2 (the virus that causes COVID-

Siemens Healthineers Announces FDA Emergency Use Authorization For CLINITEST® Rapid COVID-19 Antigen Self-Test

Varian Medical Systems

Shares in Siemens Healthineers rose on Wednesday after the German health group said it expected its newly-acquired Varian business to grow faster than other divisions in the coming three years, boosting the group's revenue.

Siemens Healthineers bets on Varian to boost growth

MALVERN, Pa.--(BUSINESS WIRE)--Siemens Healthineers is proud to be recognized in Stage I of the Foundation for the National Institutes of Health (FNIH) Biomarkers Consortium Non-Invasive Biomarkers of Metabolic Liver Disease (NIMBLE) study. The data from “LO1: Primary Results of the NIMBLE Stage 1-NASH CRN Study of Circulating Biomarkers for Nonalcoholic Steatohepatitis and its Activity and Fibrosis Stage,” presented in a late-breaking oral presentation at The Liver Meeting 2021 on Sunday, Nove

Siemens Healthineers Proud to be Recognized in a Study Conducted by the Foundation for the National Institutes of Health

Siemens Healthineers AG (SEMHF) CEO Bernd Montag on Q4 2021 Results - Earnings Call Transcript

Bit Digital, Inc

Support.com

AeroCentury

Creatd Inc

A new list from Fintel offers a look at a group of five tickers that analysts believe could be prime candidates for short squeeze stocks. The post Short Squeeze Stocks: BTBT, SPRT and 3 Others Experts Think Are Ready to Pop appeared first on InvestorPlace.

Short Squeeze Stocks: BTBT, SPRT and 3 Others Experts Think Are Ready to Pop

TAMPA BAY, Fla., Aug. 5, 2021 /PRNewswire/ -- Siemens Healthineers has recently started offering its customers WeScan1.

TeamViewer and Siemens Healthineers Form Partnership to Enable New Remote Scanning Service WeScan for Diagnostic Imaging

Siemens Healthineers AG (SEMHF) CEO Bernd Montag on Q3 2021 Results - Earnings Call Transcript

MINNEAPOLIS--(BUSINESS WIRE)--Flywheel, the leading data management platform for medical research and collaboration, announces a partnership with Siemens Healthineers.

Flywheel and Siemens Healthineers Partner for Healthcare Research Collaboration

MALVERN, Pa.--(BUSINESS WIRE)--Siemens Healthineers announces the Food and Drug Administration (FDA) clearance of the MAGNETOM Free.Max, a new High-V magnetic resonance (MR) scanner that combines a 0.55 Tesla (0.55T) field strength with deep learning technologies and advanced image processing. By doing so, the scanner broadens the range of MR clinical applications and provides customers with the inherent clinical benefits of a mid-field MR scanner. The first and only 80 cm wide-bore system avai

Siemens Healthineers Announces FDA Clearance of MAGNETOM Free.Max 80 cm MR Scanner

Infineon Technologies AG

Koninklijke KPN NV

Logitech

Lonza Group AG

Prosus NV

Schneider Electric SE

Rentokil Initial PLC

The stocks could turn out to be winners in coming months if analysts' upbeat calls turn out to be correct.

12 European Stocks That Analysts Love and Investors Are Ignoring

Siemens Healthineers AG (SEMHF) CEO Bernd Montag on Q2 2021 Results - Earnings Call Transcript

Siemens Healthineers AG (ETR: SHL) reported an increase in its second-quarter profit and revenue on Monday as demand remained resilient in recent months. On the back of hawkish quarterly performance, Siemens Healthineers also raised its full-year guidance.

Siemens Healthineers' profit jumps to £389 million in fiscal Q2

NEW YORK, NY / ACCESSWIRE / May 3, 2021 / Siemens Healthineers AG (OTC PINK:SMMNY) will be discussing their earnings results in their 2021 Second Quarter Earnings call to be held on May 3, 2021 at 8:00 AM Eastern Time.

Siemens Healthineers AG to Host Earnings Call

German health technology company Siemens Healthineers raised its full-year sales and profit forecast on Monday, as the global COVID-19 pandemic continues to drive demand for its rapid antigen tests.

Siemens Healthineers raises outlook on demand for rapid COVID tests

Siemens' pivot toward the growth markets of industrial automation should make it quite attractive for investors. But that's hardly the only reason to buy it.

My Top International Stock to Buy Now

EU antitrust regulators are set to grant conditional clearance to German health group Siemens Healthineers' $16.4-billion bid for U.S. peer Varian Medical Systems Inc, three people familiar with the matter said.

Exclusive: EU antitrust regulators to okay Siemens Healthineers' $16.4 billion Varian buy - sources

Siemens Healthineers AG (SEMHF) CEO Bernd Montag on Q1 2021 Results - Earnings Call Transcript

In an announcement on Monday, Siemens Healthineers AG (ETR: SHL) said that its net profit in the fiscal first quarter posted a 44% annualised growth to £384.80 million. The company said that its rapid antigen tests saw robust demand in recent months as the new variant of the Coronavirus pandemic wreaked havoc in Germany.

Siemens Healthineers' net profit jumps 44% in the fiscal first quarter

Siemens Healthineers is a the medical technology spin-off of Siemens and went public in early 2018. The current fiscal year has been very challenging for the company, but overall results are better than they seem, and FY2021 should see the company return to growth.

Siemens Healthineers: A Rising Star

Siemens Healthineers stock climbed on Thursday, as Bank of America and Commerzbank both upgraded the German medical equipment maker to buy.

Siemens Healthineers Gets 2 Upgrades. Here's Why.

Siemens Healthineers AG (SEMHF) CEO Bernhard Montag on Q4 2020 Results - Earnings Call Transcript

MALVERN, Pa. & IOWA CITY, Iowa--(BUSINESS WIRE)--Siemens Healthineers and University of Iowa Health Care have established a 10-year Value Partnership that builds on a long-standing relationship and will help advance care in Iowa over the next decade. The partnership will provide Iowans with access to cutting-edge imaging technology; use artificial intelligence and data analytics to improve performance and efficiency; expand research opportunities; and invest in workforce training and developmen

News for Siemens Healthineers AG Stock (SMMNY)